Literature DB >> 8823826

The steroid-eluting electrode: a 10-year experience.

H G Mond1, K B Stokes.   

Abstract

The benefits of steroid-eluting electrodes in reducing stimulation thresholds are well established. A question frequently asked, however, is how long does such an electrode maintain its effect on reducing stimulation threshold? Two studies were designed to answer this question by reporting a long-term prospective human implant review as well as an analytical examination of explanted leads from both humans and animals to determine the amount of remaining steroid in the silicone plug. A previously reported double-blind human study using 20 implanted unipolar ventricular leads, 10 with and 10 without steroid, was followed for 10 years. Pulse width stimulation thresholds were determined at regular intervals using a customized VVIC pulse generator programmed to 1.5-V output. Throughout the study period, the mean stimulation thresholds for the steroid-eluting leads remained almost constant, with a narrow standard deviation, whereas the leads without steroid showed an unpredictable rise and a wide standard deviation. All patients with the steroid-eluting electrodes were paced at 1.5 V, and the four surviving patients still have their original pulse generators. In the second study, the remaining steroid from 25 explanted leads (18 canine and 7 human), were analyzed and graphed against implant times that ranged from 1-350 weeks. Extrapolation of the line of best fit suggests that about 20% of the steroid is still present at 10 years and 18% at 20 years. Only small quantities of steroid are required for its stimulation threshold lowering effect, which continues clinically to at least 10 years. Sufficient quantity of steroid may well be present at 20 years.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823826     DOI: 10.1111/j.1540-8159.1996.tb03407.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  Short and medium time experience with a tined, multilumen steroid eluting defibrillation lead.

Authors:  Halfdan Aass; Joseph Ilvento
Journal:  J Interv Card Electrophysiol       Date:  2002-02       Impact factor: 1.900

2.  Minimally Invasive Implantation of a Micropacemaker Into the Pericardial Space.

Authors:  Yaniv Bar-Cohen; Michael J Silka; Allison C Hill; Jay D Pruetz; Ramen H Chmait; Li Zhou; Sara M Rabin; Viktoria Norekyan; Gerald E Loeb
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-07

Review 3.  The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives.

Authors:  Syed Hassan Abbas Kazmi; Sudarshana Datta; Gerald Chi; Tarek Nafee; Megan Yee; Akshun Kalia; Sadaf Sharfaei; Fahimehalsadat Shojaei; Sabawoon Mirwais; C Michael Gibson
Journal:  Med Devices (Auckl)       Date:  2020-01-07

4.  Analysis of fractal electrodes for efficient neural stimulation.

Authors:  Laleh Golestanirad; Behzad Elahi; Alberto Molina; Juan R Mosig; Claudio Pollo; Robert Chen; Simon J Graham
Journal:  Front Neuroeng       Date:  2013-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.